Mechanism study of Doppel protein in human colorectal cancer : 인간 대장암에서 도펠 단백질의 메커니즘 규명

Cited 0 time in Web of Science Cited 0 time in Scopus
약학대학 제약학과
Issue Date
서울대학교 대학원
학위논문 (석사)-- 서울대학교 대학원 : 약학대학 제약학과, 2018. 8. 변영로.
Angiogenesis is a biological process that is essential not only for normal tissue growth and development but also for cancer growth and metastasis. Although anticancer agents that inhibit angiogenesis have been actively developed, there is a limit in that the target of these agents are commonly expressed in both normal tissues and cancers, so that the angiogenesis is inhibited without any distinction. Herein, this study targeted the colorectal cancer and identified the mechanism of protein 'Doppel,' which is expressed much more in tumor endothelial cells than normal endothelial cells.

Experimental results showed that Doppel antibody reduced phosphorylation of VEGFR-2 & FGFR-1, the two most essential receptors involved in angiogenesis and Doppel is located from 10 nm range with FGFR-1 on the cell membrane.

Furthermore, Doppel antibody also affected β-catenin and STAT 5a which are related to VEGF-A expression and sensitivity of chemotherapeutic agents to colorectal cancer. In animal models of colorectal cancer, Doppelantibody showed more than 50% anticancer effect. Taken together, Doppel is associated with both angiogenesis and chemotherapeutic sensitivity in colorectal cancer. This study is novel in that it is the first study of Doppel's role in colorectal cancer. The detailed mechanism which will be studied in future research would allow the colorectal cancer patients to use the Doppel antibodies as a way to overcome the limitations of cancer recurrence, resistance, and side effects associated with conventional anticancer agents.
Files in This Item:
Appears in Collections:
College of Pharmacy (약학대학)Dept. of Manufacturing Pharmacy (제약학과)Theses (Master's Degree_제약학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.